These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34835256)

  • 1. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.
    Tobaiqy M; MacLure K; Elkout H; Stewart D
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
    Aldali J; Meo SA; Al-Khlaiwi T
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.
    Tobaiqy M; Elkout H; MacLure K
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33923530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
    Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.
    Sharif N; Opu RR; Saha T; Khan A; Aljohani A; Alsuwat MA; García CO; Vázquez AA; Alzahrani KJ; Miramontes-González JP; Dey SK
    Sci Rep; 2024 Oct; 14(1):23794. PubMed ID: 39394252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data.
    Primorac Padjen E; Marcec R; Zidar M; Padjen I; Katanec T; Anic B; Likic R
    Rheumatol Int; 2024 Feb; 44(2):273-281. PubMed ID: 38142450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose.
    Ríos E; Medrano S; Martínez M; Novella C; Marcos E; Fernández JJ; Delgado-Iribarren A; Culebras E
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines.
    Sessa M; Kragholm K; Hviid A; Andersen M
    Expert Opin Drug Saf; 2021 Nov; 20(11):1451-1453. PubMed ID: 34264151
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events following administration of COVID-19 vaccines in Saudi Arabia.
    Alqahtani S; Jokhdar H; Al-Tawfiq JA; Al-Otaibi S; Assiri A; Almudarra S; Alabdulkareem K; Haji A
    Sci Rep; 2022 Nov; 12(1):19551. PubMed ID: 36379996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines.
    Marcec R; Likic R
    Postgrad Med J; 2022 Jul; 98(1161):544-550. PubMed ID: 34373343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
    Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
    Front Immunol; 2022; 13():965171. PubMed ID: 36263025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine.
    Abukhalil AD; Abushehadeh RR; Shatat SS; Al-Shami N; Naseef HA; Ladadweh H; Madia R
    Int J Gen Med; 2024; 17():3349-3360. PubMed ID: 39100722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia.
    AlRuthia Y; Al-Salloum HF; Almohammed OA; Alqahtani AS; Al-Abdulkarim HA; Alsofayan YM; Almudarra SS; AlQahtani SH; Almutlaq A; Alabdulkareem K; Balkhi B; Almutairi HT; Alanazi AS; Asiri YA
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.